Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Vanderbilt University

Status

Completed

Conditions

Metastatic Cancer

Liver Cancer

Treatments

Procedure: quality-of-life assessment

Other: questionnaire administration

Other: medical chart review

Study type

Observational

Funder types

Other

NIH

Identifiers

NCT00482586

VU-VICC-GI-0372 (Other Identifier)

P30CA068485 (U.S. NIH Grant/Contract)

VU-VICC-IRB-020874 (Other Identifier)

CDR0000546520

Details and patient eligibility

About

RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future.

PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

Full description

OBJECTIVES:

Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies.

OUTLINE: This is a pilot, prospective, longitudinal study.

Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review.

PROJECTED ACCRUAL: Not specified

Enrollment

137 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques:
- X-ray
- Ultrasound
- MRI
- CT scan
- Nuclear medicine imaging

PATIENT CHARACTERISTICS: